Section Arrow
INDV.NASDAQ
- Indivior PLC
Quotes are at least 15-min delayed:2025/02/23 06:35 EST
Last
 8.45
-0.54 (-6.01%)
Day High 
9.015 
Prev. Close
8.99 
1-M High
12.43 
Volume 
1.75M 
Bid
8.34
Ask
12.69
Day Low
8.38 
Open
8.82 
1-M Low
8.98 
Market Cap 
1.12B 
Currency USD 
P/E 327.25 
%Yield -- 
10-SMA 10.03 
20-SMA 10.94 
50-SMA 11.5 
52-W High 23.22 
52-W Low 7.33 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.03/0.08
Enterprise Value
1.39B
Balance Sheet
Book Value Per Share
-1.35
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
901.00M
Operating Revenue Per Share
8.07
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
UPCUniverse Pharmaceuticals Inc0.2003+0.0578+40.56%-- 
TLRYTilray Brands0.9452+0.0775+8.93%-- 
CGCCanopy Growth Corp1.615+0.005+0.31%-- 
TXMDTherapeuticsMD1.291+0.281+27.82%0.39PE
TEVATeva Pharmaceutical Industries Limited16.74-0.26-1.53%-- 
Quotes are at least 15-min delayed:2025/02/23 06:35 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.